×
Log in
Get Started
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Explore all categories
Report -
Palbociclib (IBRANCE®): Dossier zur Nutzenbewertung gemäß ... · Dossier zur Nutzenbewertung – Modul 3 B Stand: 28.09.2018 Vergleichstherapie, Patienten mit therap. bedeutsamem
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form